Bausch & Lomb (Rochester, New York) said that it is making “adjustments” to its worldwide workforce over the next several months, reducing about 400 positions, the majority of them temporary jobs, it said, in Europe and the U.S.
The company said it will continue to adjust its temporary workforce to meet changing business conditions, and that it expects to rehire some of these temporary employees in the new year.
B&L had added to its temporary workforce for production of its PureVision silicone hydrogel contact lens. In addition, B&L is transitioning its contact lens lines, including its one-day products, to newer designs, which are produced using more automated manufacturing technology. The “adjustments” affect plants in Waterford, Ireland; Livingston, Scotland; and Rochester, New York. B&L makes soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products.
Aethlon to present at AIDS conference
Aethlon Medical (SAN DIEGO) reported that its president, Hal Handley, PhD, will present at the U.S. Conference on AIDS (USCA) on Sept. 22 in Hollywood, Florida.
Handley will review targeted applications of the Aethlon Hemopurifier, including its potential to combat drug-resistant HIV during “The Biotech Research Forum,” a showcase of advances in HIV/AIDS treatment.
Aethlon makes products to treat infectious disease.